Navigation Links
Screening Proposed for Childhood Cholesterol Levels
Date:9/13/2007

Treatment would reduce risk of genetic condition that can lead to early death

THURSDAY, Sept. 13 (HealthDay News) -- A simple blood test early in life could identify children with familial hypercholesterolemia, a genetic condition that causes high cholesterol levels and greatly increases the risk of early death from heart disease, a British study finds.

Drug treatment could eventually be started to reduce that risk. And a side benefit could be identification of parents unaware that they were carrying the gene for the condition, the researchers said.

No elaborate genetic test would be needed, just a blood reading to find which children have abnormally high levels of LDL cholesterol -- the "bad" kind associated with blockage of arteries, said Dr. David Wald, lead author of the report.

The findings are published online Sept. 15 in the British Medical Journal.

An analysis of 13 studies that included 1,907 people with the condition showed that screening was most effective when done early in childhood, said Wald, a consultant cardiologist and senior lecturer at the Wolfson Institute of Preventive Medicine in London.

"The work we've done establishes the age at which screening performance is optimized," Wald said. He and his colleagues are planning "a limited implementation study that is necessary to establish feasibility," he said. The proposal is to include a cholesterol test at about 15 months of age, as part of a child's normal health-care routine.

Screening newborns or young adults was much less effective, the report said.

"Our study shows that a test would identify 88 percent of cases of familial hypercholesterolemia, with only one in 1,000 misidentified," Wald said.

The more common form of the condition, caused by a single gene, is estimated to occur in one of every 500 people in Great Britain and the United States. There are rare, much more severe cases of th
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Need for Colon cancer screening
2. The Use Of MRI For Screening Of Breast Cancer Questioned
3. Early Screening For Cancer May Save Lives
4. Mobile Endoscopic Facilities For Health Screening
5. DNA biochip for genetic screening
6. Breast screening among diabetic women
7. Screening device for ovarian cancer
8. Fast screening for macular degeneration
9. Screening bypasses radical breast surgery
10. Screening of Lazy Eye
11. New virtual colonoscopy procedure for easier colon screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)...July 9 /PRNewswire/ -- leViv, Inc. (http://www.le... nutrition and lifestyle programs for,individual h.... The new,programs include 28-days of delicious, d...r 110 items in every order), online recipes, healt...urces, professional advice,news, health informati...
(Date:7/9/2008)... /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE...s to the global life,sciences markets, today annou...mited (AECL) with notice of arbitration proceeding...fulfill its contractual obligations,under its 2006...d if not,granted, seeking significant monetary dam...
(Date:7/9/2008)... adds to its unparalleled content on breastfeeding... professional articles on child, health, from alle...lking., BOULDER, Colo., July 9 /PRNewswire/ -- Br...verything for the New Mom, improves its already,un... doctor-reviewed,professional articles on infant, ...
(Date:7/9/2008)... DRE, Inc., a premier international surgical...mers that as much as $250,000 in medical equipment...lings. , Louisville, KY (...f 2008, in accordance with Tax Code Section 179, c...t bought in 2008. This could make 2008 an attracti...
Breaking Medicine News(10 mins):Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 2Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 3Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 2Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 3Health News:Breastfeeding.com Becomes a Premier Resource on Child Health 2Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2
... in more than a year has highlighted growing compl...mains endemic in the country, experts said Sunday ...he capital Hanoi was killed by the H5N1 strain a w... more people are known to have been infected with ...
...rn after embryo biopsy for preimplantation genetic...mations than those born after artificial reproduct... option for couples at risk of transmitting geneti...a prenatal diagnosis followed by a termination of ...
...wo minutes to cut the umbilical cord after birth, ... reduces the risk of blood disorders . The study ... Hamilton, Canada, and involved more than 1,900 ne...ssistant dean of midwifery at the university, said...
...fied potential chinks in the parasite that causes ...isease that afflicts some 12 million people around...protozoa that cause most cases of leishmaniasis co...ackling this neglected disease are already slender...
Other Medicine News:Health News:Vietnam Bird Flu Death a Call for Action, Say Experts 2Health News:Vietnam Bird Flu Death a Call for Action, Say Experts 3Health News:Children Born After PGD as Healthy as Kids Born After ART 2Health News:2 Minute Delay in Cutting Cord can Give Babies a 'significant' Health Boost 2Health News:Gene Study Throws Up New Targets for Leishmaniasis 2
(Date:7/6/2008)... BD GeneOhm(TM) Cdiff Assay Submitted for F...Call/ -- BD Diagnostics, a segment,of BD (Becton, ...day the CE,marking of the BD GeneOhm(TM) Cdiff mol...ith Clostridium difficile infection (CDI). It is t...ty, simplicity and speed in one test,procedure. BD...
(Date:7/3/2008)... SAN FRANCISCO, July 3 /- M...hat it will hold a teleconference at 5:00,p.m. EDT...om its,randomized, double-blind, placebo-controlle...ton,s disease., Teleconference/Webcast Details, ... at 5:00 p.m. Eastern,time by telephone, please di...
(Date:7/3/2008)... NEW BRUNSWICK, N.J., July 3 /PRNewswire-FirstCall..."Company") (Amex: SNT ) announced today,that it h...("VGXI") to,supply the plasmid portion of the Comp... 5A gene and siRNA against Factor 5A., Senesco ha... results,using its combination siRNA and plasmid a...
(Date:7/2/2008)... - Top-line Data Expected in Augus... Isolagen(TM), Inc. (Amex:,ILE) announced today th...s,Phase III clinical studies (IT-R-005/006) invest... of nasolabial folds, or wrinkles. The last,person...follow-up visit,and collation of this data has be...
Breaking Medicine Technology:BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 2BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 3Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease 2Senesco Chooses VGXI to Produce Factor 5A Plasmid 2Senesco Chooses VGXI to Produce Factor 5A Plasmid 3Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 2Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 3Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 1Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 2Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 3Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 4Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 5Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 6Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 7Mexicos expanded health insurance improves hypertension treatment 5750 1Mexicos expanded health insurance improves hypertension treatment 5750 2New research to help fight widespread potato disease 1140 1New research to help fight widespread potato disease 1140 2Pollution from marine vessels linked to heart and lung disease 1137 1Pollution from marine vessels linked to heart and lung disease 1137 2
...evention of Cervical Cancer and Other Human,Papill... of Follow,Up in Large Phase III Clinical Studies ...nd Journal of Medicine publishes the most comprehe...lomavirus vaccine , LYON, France, 10th May2007 &nd...nd sustained efficacy of Gardasil® in the,prev...
... Germany, May 10th, 2007 - Antisense,Pharma today ...minary Results of a Phase I/II-Study in Pancreatic...cinoma with the,TGF-beta2 Inhibitor AP 12009&rdquo... 43rd Annual Meeting of the American Society of,Cl...ago, Illinois,U.S.A, from June 1st - 5th. , In th...
Other Medicine Technology:Gardasil Demonstrates Up to 100% Efficacy 2Gardasil Demonstrates Up to 100% Efficacy 3Gardasil Demonstrates Up to 100% Efficacy 4Gardasil Demonstrates Up to 100% Efficacy 5Gardasil Demonstrates Up to 100% Efficacy 6Gardasil Demonstrates Up to 100% Efficacy 7Phase I/II-data on Systemic Application of the TGF-beta2-inhibitor,AP 12009 to be Presented 2
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: